When Misty was 11, her father had a heart attack. When Misty was 29, her elder sister passed away due to complications of heart disease. When Misty was 44, her middle sister passed away from a heart attack. That’s when Misty went to the doctor and learned that her Lp(a) was extremely high. A genetic and inherited condition, high Lp(a) can result in a higher risk for heart disease and stroke. With this newfound diagnosis and with help from the Family Heart Foundation, Misty’s been able to gain clarity and make connections with other people who have had similar experiences. March 24 is Liproprotein(a) Awareness Day. To learn more about Misty and see how you can discover your Lp(a) levels, click the image. #WeAreLilly #knowLpa
关于我们
We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine,?contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.
- 网站
-
https://www.lilly.com/
礼来的外部链接
- 所属行业
- 制药业
- 规模
- 超过 10,001 人
- 总部
- Indianapolis，Indiana
- 类型
- 上市公司
- 领域
- Pharmaceutical Development、Pharmaceuticals、Biotech和Biopharmaceuticals
地点
-
主要
获取路线
Lilly Corporate Center
US，Indiana，Indianapolis，46285
礼来员工
动态
-
Purpose, people and bold science fuel our progress on behalf of patients. In 2024, we helped more than 58 million people have a chance at better health. Read more in our annual Year in Review: https://e.lilly/4ivnKs2.
-
-
You don’t choose to become ill. You don’t choose for your loved ones to become ill. You don’t choose to fight countless battles that are yet to be won. That’s why we pursue bold science, take risks and push the limits of what’s possible. That’s why we work every single day to drive progress for patients. Yesterday Fast Company named us one of the most innovative companies in medicines and therapeutics. Thanks to everyone who makes this cutting-edge work possible. Find out more about what we’re working on here: https://e.lilly/4kRi39t #WeAreLilly #FCMostInnovative
-
-
When people take our medicines, they’re placing enormous trust in our science, quality and integrity. We owe them our best – a promise that’s at the heart of all we do. Thanks to Ethispherefor recognizing us as one of the #WorldsMostEthicalCompanies again this year. #WeAreLilly
-
Severe alopecia areata is a chronic immune system disorder that can have a significant impact on adolescents and their families. New results from a clinical study highlight promising findings for a potential treatment option for this chronic immune system condition. Discover the data presented at #AAD2025: https://e.lilly/41PeLvI
-
Jirong Lu, one of the most accomplished scientists in our company’s history, has dedicated her career to discovering medicines that help people – including our treatment for Alzheimer’s disease. But she hasn’t often met the people who have benefited from her groundbreaking research. When Myra Garcia—who lives with Alzheimer’s disease—visited our corporate center in Indianapolis, the two became fast friends. This International Women’s Day, we’re celebrating the impact of women in science and the brave voices of patients like Myra. See her full story at https://e.lilly/4iqGEzE. #IWD2025 #WeAreLilly
-
For millions of people impacted by Alzheimer’s disease, hope lies with the people who are working tirelessly to find bold advances in science that may lead to new treatments. Potentially, even cures. We feel honored that some of the most brilliant minds, who have shown the greatest tenacity in studying this disease, are part of our team. That includes our Chief Scientific Officer Daniel Skovronsky who was recently awarded the prestigious Melvin R. Goodes Prize for Excellence in Drug Development from the Alzheimer’s Drug Discovery Foundation. Dan, congratulations on being recognized for your exceptional contributions to help patients and caregivers. #WeAreLilly
-
-
People with moderate-to-severe #AtopicDermatitis experience recurring and unpredictable flares and need long-term treatment options that can help address their symptoms. New long-term data presented at #AAD2025 highlight 3-year symptom reduction as well as results from assessments in populations of high unmet need with FDA-approved medicine. Discover the data: https://e.lilly/3DaV5Jr
-
World Obesity Day is dedicated to supporting healthier lives for people living with obesity. This year, we’ve teamed up with World Obesity Federation to raise awareness and spark action. Obesity is a complex disease and deserves to be treated as seriously as other chronic diseases. We need to work together to transform the status quo. #worldobesityday #WeAreLilly
-
-
Edgar often felt tired but chalked it up to just being “a sleepy person.” When he was diagnosed with obstructive sleep apnea in his ‘20s, he began to understand why. Learn more: https://e.lilly/3QI08UA #WeAreLilly